Quick Answer
Exousia Bio, Inc. reported Diluted EPS of $0.00 per share for fiscal year 2025.
Exousia Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.00 | — |
| 2024 | $0.00 | — |
| 2023 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $0.00 | -100.0% | — |
| August 31, 2025 | $0.00 | — | — |
| February 28, 2025 | $0.00 | — | -100.0% |
| November 30, 2024 | $0.01 | — | — |
| August 31, 2024 | $0.00 | — | — |
| February 29, 2024 | $0.00 | — | — |
| November 30, 2023 | $0.00 | — | — |
| August 31, 2023 | $0.00 | — | — |
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: